156 related articles for article (PubMed ID: 5012351)
1. [Amantadine. Prolonged clinical trial in 50 parkinsonian patients].
Castaigne P; Laplane D; Dordain G
Nouv Presse Med; 1972 Feb; 1(8):533-6. PubMed ID: 5012351
[No Abstract] [Full Text] [Related]
2. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
Hacohen H; Gurtner B
Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
[No Abstract] [Full Text] [Related]
3. L-dopa and amantadine in the therapy of parkinsonism.
Weeth JB; Shealy CN; Mercier DA
Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
[No Abstract] [Full Text] [Related]
4. [Treatment of Parkinson's disease with amantadine].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
[No Abstract] [Full Text] [Related]
5. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
6. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
7. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Schwab RS; England AC
Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
[No Abstract] [Full Text] [Related]
8. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
Ambrosetto C; Martinelli P
Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
[No Abstract] [Full Text] [Related]
9. Amantadine in the treatment of Parkinson's disease.
Schwab RS; England AC; Poskanzer DC; Young RR
JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715
[No Abstract] [Full Text] [Related]
10. Treatment of Parkinson's disease with amantadine and L-Dopa.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
[No Abstract] [Full Text] [Related]
11. Parkinson's disease and amantadine hydrochloride.
JAMA; 1969 May; 208(7):1180-1. PubMed ID: 5818720
[No Abstract] [Full Text] [Related]
12. [Amantadine therapy in parkinsonism].
Pakkenberg H
Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048
[No Abstract] [Full Text] [Related]
13. [Preliminary results of the use of amantadine in parkinsonian syndromes].
Montanari M; Monaco V; Robotti CA
Minerva Med; 1971 Oct; 62(82):3955-7. PubMed ID: 5125050
[No Abstract] [Full Text] [Related]
14. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
Matsumoto K; Omoto T; Beck H
Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
[No Abstract] [Full Text] [Related]
15. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism].
Danielczyk W; Korten JJ
Med Monatsschr; 1971 Oct; 25(10):472-9. PubMed ID: 5122447
[No Abstract] [Full Text] [Related]
16. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
De la Herrán J; Figuerido JA
Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
[No Abstract] [Full Text] [Related]
17. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
Ciuca I; Bulandra R; Serbanesco A; Ninosu N
Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
[No Abstract] [Full Text] [Related]
18. Levodopa and amantadine in the treatment of Parkinsonism.
Critchley E
Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
[No Abstract] [Full Text] [Related]
19. The comparative value of amantadine and levodopa.
Dallos V; Heathfield K; Stone P; Allen F
Postgrad Med J; 1972 Jun; 48(560):354-8. PubMed ID: 4558895
[TBL] [Abstract][Full Text] [Related]
20. [Current treatment of Parkinsonism with amantadine hydrochloride].
Gerstenbrand F; Gründig E; Musiol A
Pol Tyg Lek; 1972 Jul; 27(23):878-9. PubMed ID: 5040531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
